Business description: United Therapeutics Corporation

United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.

Number of employees: 1,168

Sales by Activity: United Therapeutics Corporation

Fiscal Period: December20192020202120222023

Pharmaceuticals

1.45B 1.48B 1.69B 1.94B 2.33B
See all business segments

Geographical breakdown of sales: United Therapeutics Corporation

Fiscal Period: December20192020202120222023

United States

1.32B 1.41B 1.56B 1.81B 2.2B

Rest of World

126M 71.2M 121M 122M 125M
See all geographic segments

Managers: United Therapeutics Corporation

Manager TitleAgeSince
Chief Executive Officer 69 25/06/96
Director of Finance/CFO 56 31/12/12
General Counsel 60 25/06/96
See UNITED THERAPEUTICS CORPORATION governance

Members of the board: United Therapeutics Corporation

Director TitleAgeSince
Director/Board Member 76 31/12/01
Chief Executive Officer 69 25/06/96
Director/Board Member 90 31/12/01
Composition of the Board of Directors

Shareholders: United Therapeutics Corporation

NameEquities%Valuation
BlackRock Advisors LLC
11.35 %
5,037,364 11.35 % 1 605 M $
The Vanguard Group, Inc.
10.57 %
4,687,393 10.57 % 1 493 M $
Vanguard Fiduciary Trust Co.
10.56 %
4,683,095 10.56 % 1 492 M $
Wellington Trust Co., NA
7.691 %
3,412,260 7.691 % 1 087 M $
Avoro Capital Advisor LLC
6.444 %
2,858,888 6.444 % 911 M $
List of UNITED THERAPEUTICS CORPORATION shareholders

Holdings: United Therapeutics Corporation

NameEquities%Valuation
796,885 3.66% 2,494,250 $
2,869,517 2.23% 1,021,548 $

Company details: United Therapeutics Corporation

United Therapeutics Corp.

1000 Spring Street

20910, Silver Spring

+301 608 9292

http://www.unither.com
address United Therapeutics Corporation(UTHR)

Other Biotechnology & Medical Research

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.24%+2.61%+35.65%+82.45% 14.94B
-1.02%-3.11%-4.10%-65.24% 46.47B
-2.63%+2.50%+4.61%-4.13% 43.53B
-0.56%+1.40%+6.21%-26.11% 42.23B
-0.55%-6.22%+17.10%+28.44% 29.64B
-2.07%+0.26%+25.30%-25.25% 28.11B
-2.27%-4.04%+35.09%+52.40% 27.47B
-18.27%-21.87%+45.67%+96.19% 11.05B
-1.62%-4.15%-14.44%-35.49% 12.06B
-3.22%-3.09%+6.74%-44.42% 11.35B
Average -2.72%-3.77%+15.78%+5.88% 26.68B
Weighted average by Cap. -1.49%-2.28%+12.72%-5.17%
See all sector performances
  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. Company United Therapeutics Corporation